Other substances

Cefuroxime

A cephalosporin antibiotic.

Phase of research

Potential treatment - theoretical effect

How it helps

Antiviral

Drug status

Used to treat other disease

1
 Supporting references
0
 Contradictory references
5
 AI-suggested references
0
 Clinical trials

General information

Cefuroxime on PubChem

Marketed as

CEFTIN; CEFURAX; CEFUROXIME; CEFUROXIME AXETIL; ELOBACT; KEFUROX; ORAXIM; SHAROX; SUPACEF; ZINACEF; ZINNAT

 

Structure image - Cefuroxime

CO/N=C(/C1=CC=CO1)\C(=O)N[C@H]2[C@@H]3N(C2=O)C(=C(CS3)COC(=O)N)C(=O)O

Supporting references

Link Tested on Impact factor Notes Publication date
The study of antiviral drugs targeting SARS-CoV-2 nucleocapsid and spike proteins through large-scale compound repurposing
Nucleocapsid protein Small molecule In silico 		in silico

Predicted to bind SARS-CoV-2 Nucleocapsid protein.

 Mar/01/2021

AI-suggested references

Link Publication date
COVID-19 rapid guideline: antibiotics for pneumonia in adults in hospital
Nov/07/2021
SARS-CoV-2 RNA dependent RNA polymerase (RdRp) targeting: an in silico perspective
May/06/2020
Antiviral drugs against severe acute respiratory syndrome coronavirus 2 infection triggering the coronavirus disease-19 pandemic
Dec/04/2020
In Silico Screening of Bioactive Compounds of Representative Seaweeds to Inhibit SARS-CoV-2 ACE2-Bound Omicron B.1.1.529 Spike Protein Trimer
Mar/25/2021
Binary-QSAR guided virtual screening of FDA approved drugs and compounds in clinical investigation against SARS-CoV-2 main protease
Aug/30/2021
Export (.csv)